Skip to main content
. 2017 Nov 10;2017:6873281. doi: 10.1155/2017/6873281

Figure 7.

Figure 7

Schema showing the potential actions of edaravone against reactive oxygen species in thrombolytic pathways. Those in red indicate mechanisms suggested by the findings of our study. tPA: tissue plasminogen activator; FbP: fibrin degradation product; FgDP: fibrinogen degradation product.